Managing Unexplained Symptoms (chronic widespread pain) In primary Care: Involving traditional and Accessible New approaches
- Conditions
- Chronic Widespread Pain (CWP)Musculoskeletal DiseasesSoft tissue disorders
- Registration Number
- ISRCTN67013851
- Lead Sponsor
- niversity of Aberdeen (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 552
1. Satisfy the American College of Rheumatology (ACR) definition of Chronic Widespread Pain (CWP) as used in the criteria for fibromyalgia
2. Symptoms have an impact on physical function as assessed by the Chronic Pain Grade Questionnaire
3. Consulted their general practitioner because of these symptoms within the past year
4. Have access to a landline telephone
5. Age above 25 years (both genders will be included)
Patients who have contraindications for prescribed exercise or cognitive behavioural therapies, as determined by their GPs or the research nurse.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome of the trial will be a self-rated clinical global impression change score at 6 (end of intervention) and 9 months post-randomisation. This is a seven-point scale measuring how participants feel that their health has changed since the period prior to entering the trial. It ranges from I feel much worse (score 1) to I feel better (score 6) and I feel much better (score 7).
- Secondary Outcome Measures
Name Time Method 1. Pain<br>2. Fatigue<br>3. Coping<br>4. Psychological distress<br>5. Sleep problems<br>6. Fear of movement<br>7. Quality of life<br>8. Treatment side-effects<br><br>This corresponds to the recommendations of core outcome domains for chronic pain clinical trials, and outcomes considered by the Outcome Measures in Rheumatology Clinical Trials initiative. All secondary outcomes will be measured at 6 and 9 months post-randomisation.